A novel screening approach comparing kinase activity of small molecule inhibitors with similar molecular structures and distinct biologic effects in triple-negative breast cancer to identify targetable signaling pathways Matossian, Margarite D.; Burks, Hope E.; Elliott, Steven; More Matossian, Margarite D.; Burks, Hope E.; Elliott, Steven; Hoang, Van T.; Zuercher, William J.; Wells, Carrow; Drewry, David H.; Kapadia, Nirav; Chang, Tiffany; Yan, Thomas; Windsor, Gabrielle O.; Nguyen, Khoa; Fang, Fang; Nephew, Kenneth P.; Buechlein, Aaron; Rusch, Douglas B.; Sabol, Rachel A.; Ucar, Deniz A.; Zabaleta, Jovanny; Miele, Lucio; Bunnell, Bruce A.; Collins-Burow, Bridgette M.; Burow, Matthew E. Less Anti-Cancer Drugs. 31(8):759-775, September 2020. Abstract Abstract Favorites PDF Get Content & Permissions Buy SDC
Predictive and prognostic value of magnesium serum level in FOLFIRI plus cetuximab or bevacizumab treated patients with stage IV colorectal cancer: results from the FIRE-3 (AIO KRK-0306) study Schulz, Christoph; Heinemann, Volker; Heinrich, Kathrin; More Schulz, Christoph; Heinemann, Volker; Heinrich, Kathrin; Haas, Michael; Holch, Julian W.; Fraccaroli, Alessia; Held, Swantje; von Einem, Jobst C.; Modest, Dominik P.; Fischer von Weikersthal, Ludwig; Kullmann, Frank; Moehler, Markus; Scheithauer, Werner; Jung, Andreas; Stintzing, Sebastian Less Anti-Cancer Drugs. 31(8):856-865, September 2020. Abstract Abstract Favorites PDF Get Content & Permissions Buy
Timing of resumption of immune checkpoint inhibitor therapy after successful control of immune-related adverse events in seven advanced non-small cell lung cancer patients Kashiwabara, Kosuke; Fujii, Shinji; Tsumura, Shinsuke; More Kashiwabara, Kosuke; Fujii, Shinji; Tsumura, Shinsuke; Sakamoto, Kazuhiko Less Anti-Cancer Drugs. 31(8):872-875, September 2020. Abstract Abstract Favorites PDF Get Content & Permissions Buy
